0.05
0.00%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Avricore Health
Its shares trade on TSX Venture under the ticker AVCR.V. It has been listed since 31 July 2001. In the fiscal year to 31 December 2025, it reported revenue of C$533,884 and a net loss of C$1.9m. At that date it held total assets of C$563,125 and shareholders' equity of C$389,564.
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is engaged in the business of health data and point-of-care technologies (POCT). The company provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The firm's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company also provides bacterial and viral testing for Strep and COVID-19. The firm's wholly owned subsidiary is HealthTab Inc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 31 Jul 2001
- Website
- avricore.com ↗
Leadership
Pay as last reported
- Mr. David HallIndependent Chairman of the BoardC$81,425
- Mr. Rodger SeccombeChief Executive Officer, Director, since 2021C$321,442
- Ms. Kiki SmithChief Financial OfficerC$167,946
- Mr. Alan ArnsteinIndependent DirectorC$53,783
- Ms. Christine HrudkaIndependent DirectorC$26,703
- Dr. Robert SindelarIndependent DirectorC$53,783
- Mr. Thomas TeahenIndependent DirectorC$26,703
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- HealthTab enables real-time finger-stick blood tests at local pharmacies for consumers.
- The platform tests up to 27 biomarkers for managing chronic conditions like diabetes.
- Avricore Health provides digital solutions supporting pharmacists and clinical service accessibility.
Weaknesses
- The company is headquartered in Vancouver, British Columbia, which may limit local reach.
- Avricore Health went public on 31 July 2001, indicating a long listing history.
- The firm operates as a subsidiary under HealthTab Inc, potentially limiting brand autonomy.
Opportunities
- Expanding bacterial and viral testing for Strep and COVID-19 increases market relevance.
- Cloud-based network technology allows scalable infrastructure for affordable clinical services in communities.
- Point-of-care technologies support the role of pharmacists in modern healthcare systems.
Threats
- Reliance on specific biomarkers for diabetes screening may limit broader diagnostic applications.
- Competition in the health data sector could impact Avricore Health's market position.
- Regulatory changes in Canada may affect the deployment of point-of-care technologies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.